Numerous studies have shown that methyltransferase complex components (METTL3, METTL14, WTAP), demethylases (FTO, ALKBH5), and the m6A binding protein (YTHDF2, YTHDC1, and IGF2BPs) are all highly expressed in AML. Here, YTHDC1 is linked to acute myeloid leukemia.